{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:26:15Z","timestamp":1784042775487,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03185-5","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T12:02:59Z","timestamp":1722600179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum immunoglobulin levels in group E of chronic obstructive pulmonary disease: insights for clinical management and immunoglobulin therapy strategies"],"prefix":"10.1186","volume":"24","author":[{"given":"Cong Nguyen","family":"Hai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang Ta","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Bui","family":"Duc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong Hoang","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Vu","family":"Manh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"3185_CR1","unstructured":"2023 GOLD Report. Global Initiative for Chronic Obstructive Lung Disease - GOLD, https:\/\/goldcopd.org\/2023-gold-report-2\/, accessed: 05\/15\/2023."},{"key":"3185_CR2","doi-asserted-by":"crossref","unstructured":"Tanimura K, Sato S, Sato A et al. (2020). Low serum free light chain is associated with risk of COPD exacerbation. ERJ Open Res, 6(2).","DOI":"10.1183\/23120541.00288-2019"},{"key":"3185_CR3","doi-asserted-by":"crossref","unstructured":"Putcha N, Paul GG, Azar A et al. (2018). Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS. PLoS ONE, 13(4), e0194924.","DOI":"10.1371\/journal.pone.0194924"},{"issue":"8","key":"3185_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.201104-0761OC","volume":"185","author":"S Braber","year":"2012","unstructured":"Braber S, Thio M, Blokhuis BR, et al. An association between neutrophils and immunoglobulin free light chains in the pathogenesis of COPD. Am J Respir Crit Care Med. 2012;185(8):817\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"3185_CR5","doi-asserted-by":"crossref","unstructured":"McCullagh BN, Comellas AP, Ballas ZK et al. (2017). Antibody deficiency in patients with frequent exacerbations of COPD (COPD). PLoS ONE, 12(2).","DOI":"10.1371\/journal.pone.0172437"},{"issue":"5 Suppl 1","key":"3185_CR6","first-page":"S1","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol off Publ Am Coll Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1\u201363.","journal-title":"Ann Allergy Asthma Immunol off Publ Am Coll Allergy Asthma Immunol"},{"key":"3185_CR7","doi-asserted-by":"crossref","unstructured":"Holma P, Pesonen P, Karjalainen MK et al. (2023). Low and high serum IgG associates with respiratory infections in a young and working age population. eBioMedicine, 94.","DOI":"10.1016\/j.ebiom.2023.104712"},{"key":"3185_CR8","unstructured":"Ghafoor A, Joseph SM. Making a diagnosis of CVID: a review. Cureus, 12(1), e6711."},{"issue":"1Suppl 1","key":"3185_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2249.2009.04024.x","volume":"158","author":"H-P Hartung","year":"2009","unstructured":"Hartung H-P, Mouthon L, Ahmed R, et al. Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. Clin Exp Immunol. 2009;158(1Suppl 1):23\u201333.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"3185_CR10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.chest.2020.04.058","volume":"158","author":"FS Leitao Filho","year":"2020","unstructured":"Leitao Filho FS, Mattman A, Schellenberg R, et al. Serum IgG levels and risk of COPD hospitalization: a pooled Meta-analysis. Chest. 2020;158(4):1420\u201330.","journal-title":"Chest"},{"key":"3185_CR11","doi-asserted-by":"crossref","unstructured":"Cowan J, Gaudet L, Mulpuru S et al. (2015). A retrospective longitudinal within-subject risk interval analysis of Immunoglobulin Treatment for recurrent Acute Exacerbation of COPD. PLoS ONE, 10(11).","DOI":"10.1371\/journal.pone.0142205"},{"key":"3185_CR12","doi-asserted-by":"crossref","unstructured":"Wen L, Krauss-Etschmann S, Petersen F et al. (2018). Autoantibodies in COPD. Front Immunol, 9.","DOI":"10.3389\/fimmu.2018.00066"},{"key":"3185_CR13","unstructured":"GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease - GOLD, http:\/\/goldcopd.org\/gold-2017-global-strategy-diagnosis-management-prevention-copd\/, accessed: 07\/25\/2017."},{"issue":"1","key":"3185_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","volume":"39","author":"DE Furst","year":"2009","unstructured":"Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum. 2009;39(1):18\u201329.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3185_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, CEREDIH, et al. Clinical picture and treatment of 2212 patients with CVID. J Allergy Clin Immunol. 2014;134(1):116\u201326.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3185_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13223-023-00762-x","volume":"19","author":"NS Palikhe","year":"2023","unstructured":"Palikhe NS, Niven M, Fuhr D, et al. Low immunoglobulin levels affect the course of COPD in hospitalized patients. Allergy Asthma Clin Immunol. 2023;19(1):10.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"3185_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151(1):42\u201350.","journal-title":"Clin Exp Immunol"},{"key":"3185_CR18","unstructured":"Williamson Mary A, Snyder LM. (2014), Wallach\u2019s Interpretation Of Diagnostic Tests, 10 E 2014 [PDF] [Dr. Carson] VRG."},{"issue":"10","key":"3185_CR19","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3346\/jkms.2016.31.10.1560","volume":"31","author":"J-H Kim","year":"2016","unstructured":"Kim J-H, Park S, Hwang YI, et al. Immunoglobulin G Subclass Deficiencies in adult patients with chronic Airway diseases. J Korean Med Sci. 2016;31(10):1560\u20135.","journal-title":"J Korean Med Sci"},{"key":"3185_CR20","unstructured":"Samea ERA, Al Baiomy A, El-Desoky M et al. Value of Serum ECP and IgE in Differentiation between Asthma and COPD."},{"key":"3185_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2147\/COPD.S236656","volume":"15","author":"AM Holm","year":"2020","unstructured":"Holm AM, Andreassen SL, Christensen VL, et al. Hypogammaglobulinemia and risk of exacerbation and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:799\u2013807.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"3185_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, et al. Primary Immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696\u2013726.","journal-title":"J Clin Immunol"},{"key":"3185_CR23","doi-asserted-by":"crossref","unstructured":"Leitao Filho FS, Ra SW, Mattman A et al. (2018). Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD. Respir Res, 19.","DOI":"10.1186\/s12931-018-0733-z"},{"issue":"4","key":"3185_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joim.12265","volume":"276","author":"JF Bermejo-Mart\u00edn","year":"2014","unstructured":"Bermejo-Mart\u00edn JF, Rodriguez-Fernandez A, Herr\u00e1n-Monge R, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276(4):404\u201312.","journal-title":"J Intern Med"},{"key":"3185_CR25","doi-asserted-by":"crossref","unstructured":"Unninayar D, Shea B, Cameron DW et al. (2023). Levels of immunoglobulin isotypes in serum and respiratory samples of patients with COPD: protocol for a systematic review and meta-analysis. BMJ Open, 13(2), e064307.","DOI":"10.1136\/bmjopen-2022-064307"},{"issue":"6","key":"3185_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/arm90060056","volume":"90","author":"T Ba Ta","year":"2022","unstructured":"Ba Ta T, Tran Viet T, Xuan Nguyen K, et al. Changes in serum immunoglobulin G subclasses during the treatment of patients with COPD with infectious exacerbations. Adv Respir Med. 2022;90(6):500\u201310.","journal-title":"Adv Respir Med"},{"issue":"2","key":"3185_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jaci.2017.09.036","volume":"141","author":"J Cowan","year":"2018","unstructured":"Cowan J, Mulpuru S, Alvarez G, et al. COPD exacerbation frequency and serum IgG levels. J Allergy Clin Immunol. 2018;141(2):830\u20131.","journal-title":"J Allergy Clin Immunol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03185-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T12:03:12Z","timestamp":1722600192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03185-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4115367\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol underwent review and received approval from the Ethics Committee of Military Hospital 103 (No. 57\/2014\/VMMU-IRB), and all participants provided written informed consent. The methodology outlined in this manuscript strictly adheres to these approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"381"}}